Fred Alger Management, LLC Neurocrine Biosciences Inc Transaction History

Fred Alger Management, LLC

  • $22.4 Billion
  • Q3 2025

A detailed history of Fred Alger Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 2,122 shares of NBIX stock, worth $307,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,122
Previous 2,009 5.62%
Holding current value
$307,392
Previous $252,000 17.86%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$123.98 - $146.67 $14,009 - $16,573
113 Added 5.62%
2,122 $297,000
Q2 2025

Aug 14, 2025
SELL
$87.54 - $128.18 $23,198 - $33,967
-265 Reduced 11.65%
2,009 $252,000
Q1 2025

May 15, 2025
BUY
$107.22 - $153.29 $243,818 - $348,581
2,274 New
2,274 $251,000
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $8.76 Million - $11 Million
-82,599 Reduced 91.84%
7,339 $966,000
Q3 2023

Nov 14, 2023
BUY
$94.02 - $117.1 $8.46 Million - $10.5 Million
89,938 New
89,938 $10.1 Million
Q1 2023

May 15, 2023
SELL
$94.11 - $123.02 $19.4 Million - $25.4 Million
-206,521 Reduced 99.91%
176 $17,000
Q4 2022

Feb 14, 2023
BUY
$106.72 - $127.06 $22 Million - $26.2 Million
206,473 Added 92175.45%
206,697 $24.7 Million
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $16,976 - $22,415
224 New
224 $22,000
Q2 2020

Aug 14, 2020
SELL
$85.09 - $130.36 $661,574 - $1.01 Million
-7,775 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $2.29 Million - $3.48 Million
-30,550 Reduced 79.71%
7,775 $673,000
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $869,996 - $1.19 Million
10,023 Added 35.41%
38,325 $4.12 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $352,714 - $427,112
4,208 Added 17.46%
28,302 $2.55 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $1.26 Million - $1.59 Million
-17,421 Reduced 41.96%
24,094 $2.03 Million
Q1 2019

May 14, 2019
SELL
$69.31 - $91.53 $299,627 - $395,684
-4,323 Reduced 9.43%
41,515 $3.66 Million
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $986,950 - $1.8 Million
-14,446 Reduced 23.96%
45,838 $3.27 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $123,896 - $157,690
-1,253 Reduced 2.04%
60,284 $7.41 Million
Q2 2018

Jul 19, 2018
BUY
$75.3 - $105.99 $1.15 Million - $1.62 Million
15,315 Added 33.13%
61,537 $6.05 Million
Q1 2018

May 10, 2018
BUY
$75.88 - $92.43 $644,372 - $784,915
8,492 Added 22.51%
46,222 $3.83 Million
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $1.87 Million - $2.48 Million
31,905 Added 547.73%
37,730 $2.93 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $279,425 - $356,956
5,825
5,825 $357,000

Others Institutions Holding NBIX

# of Institutions
729
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email